You’re using a public version of DrugPatentWatch with 5 free searches available | Register to unlock more free searches. CREATE FREE ACCOUNT

Last Updated: April 19, 2024

THIAMINE HYDROCHLORIDE Drug Patent Profile


✉ Email this page to a colleague

« Back to Dashboard


Which patents cover Thiamine Hydrochloride, and when can generic versions of Thiamine Hydrochloride launch?

Thiamine Hydrochloride is a drug marketed by Abraxis Pharm, Bel Mar, Caplin, Dell Labs, Dr Reddys, Epic Pharma Llc, Eugia Pharma, Fresenius Kabi Usa, Hospira, Luitpold, Mylan Institutional, Parke Davis, Sagent Pharms Inc, Watson Labs, West-ward Pharms Int, and Wyeth Ayerst. and is included in seventeen NDAs.

The generic ingredient in THIAMINE HYDROCHLORIDE is thiamine hydrochloride. There are seven drug master file entries for this compound. Twelve suppliers are listed for this compound. Additional details are available on the thiamine hydrochloride profile page.

DrugPatentWatch® Litigation and Generic Entry Outlook for Thiamine Hydrochloride

A generic version of THIAMINE HYDROCHLORIDE was approved as thiamine hydrochloride by WEST-WARD PHARMS INT on December 31st, 1969.

  Try a Trial

Drug patent expirations by year for THIAMINE HYDROCHLORIDE
Recent Clinical Trials for THIAMINE HYDROCHLORIDE

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
Canadian Institutes of Health Research (CIHR)Phase 3
Hamilton Health Sciences CorporationPhase 3
Population Health Research InstitutePhase 3

See all THIAMINE HYDROCHLORIDE clinical trials

Medical Subject Heading (MeSH) Categories for THIAMINE HYDROCHLORIDE

US Patents and Regulatory Information for THIAMINE HYDROCHLORIDE

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Abraxis Pharm THIAMINE HYDROCHLORIDE thiamine hydrochloride INJECTABLE;INJECTION 080509-001 Approved Prior to Jan 1, 1982 DISCN No No ⤷  Try a Trial ⤷  Try a Trial ⤷  Try a Trial
West-ward Pharms Int THIAMINE HYDROCHLORIDE thiamine hydrochloride INJECTABLE;INJECTION 080575-001 Approved Prior to Jan 1, 1982 AP RX No No ⤷  Try a Trial ⤷  Try a Trial ⤷  Try a Trial
Dr Reddys THIAMINE HYDROCHLORIDE thiamine hydrochloride INJECTABLE;INJECTION 080571-002 Approved Prior to Jan 1, 1982 RX No Yes ⤷  Try a Trial ⤷  Try a Trial ⤷  Try a Trial
Caplin THIAMINE HYDROCHLORIDE thiamine hydrochloride INJECTABLE;INJECTION 215692-001 Mar 6, 2023 AP RX No No ⤷  Try a Trial ⤷  Try a Trial ⤷  Try a Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.